RegenXBio(DE:RB0)
€6.90-0.19 (-2.68%)
DE:RB0
RegenXBio earnings date
€6.90
At close:-0.19 (-2.68%)
RegenXBio (RB0) Q2 2022 Earnings Report
1 Followers
DE:RB0 Q2 2022 EPS Results
- Actual EPS
- -EUR 1.41
- Consensus EPS
- -EUR 1.26
- Beat/Miss
- Missed by -EUR 0.16
- One Year Ago EPS
- -EUR 1.22
DE:RB0 Q2 2022 Revenue Results
- Actual Revenue
- EUR 29.23M
- Expected Revenue
- EUR 25.35M
- Beat/Miss
- Beat by +EUR 3.88M
- YoY Revenue Growth
- +48.17%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/03/2022
- Time
- After Close
- Conference Call
- Wednesday, August 3, 2022
DE:RB0 Upcoming Earnings
RegenXBio's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RB0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.86- | -1.16 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.15-0.56 | -1.07 | 48.33% (+0.52) | |
| Aug 06, 2026 | 2026 (Q2) | 0.070.39 | -1.24 | 131.16% (+1.62) | |
| May 14, 2026 | 2026 (Q1) | -1.20-1.54 | 0.11 | -1533.33% (-1.65) | |
| Mar 05, 2026 | 2025 (Q4) | -0.86-1.16 | -0.9 | -28.71% (-0.26) | |
| Nov 06, 2025 | 2025 (Q3) | -1.15-1.07 | -1.05 | -2.56% (-0.03) | |
| Aug 07, 2025 | 2025 (Q2) | -0.84-1.24 | -0.94 | -31.43% (-0.30) | |
| May 12, 2025 | 2025 (Q1) | 0.410.11 | -1.24 | 108.70% (+1.34) | |
| Mar 13, 2025 | 2024 (Q4) | -1.02-0.90 | -1.28 | 29.37% (+0.38) | |
| Nov 06, 2024 | 2024 (Q3) | -1.00-1.05 | -1.26 | 17.02% (+0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
